Steven Gannon, Director at Xenon Pharmaceuticals Inc. (XENE), bought 15,000 shares at $2.82 ($42K) on 2017-08-11, disclosed to the SEC on 2017-08-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| XENE | SELL | 2024-03-08 | $602K | — | Filing → |
| FUSN | BUY | 2022-08-11 | $180K | — | Filing → |
| FUSN | BUY | 2021-08-23 | $23K | — | Filing → |